Evaluation of Intradermal Injection of Botulinum Toxin A for Facial Lifting
- PMID: 33488914
- PMCID: PMC7819592
Evaluation of Intradermal Injection of Botulinum Toxin A for Facial Lifting
Erratum in
-
Erratum to: Evaluation of Intradermal Injection of Botulinum Toxin A for Facial Lifting.J Clin Aesthet Dermatol. 2022 Oct;15(10):14. J Clin Aesthet Dermatol. 2022. PMID: 36312826 Free PMC article.
Abstract
BACKGROUND: Intradermal botolinum toxin A (BTXA) is an advanced technique that emerged in response to the increased demand for noninvasive facial lifting and skin rejuvenation. OBJECTIVE: We sought to evaluate the safety and efficacy of intradermal injections of BTXA for facial lifting. METHODS: Twenty-five female patients with mild symmetrical facial skin laxity were enrolled in this study. All patients were treated with BTXA in one side of the face while the other side was injected with normal saline. The response to treatment was assessed by two dermatologists who evaluated global photographs using a quartile grading scale (QGS). The patient self-assessment and satisfaction questionnaires were recorded. RESULTS: A highly significant difference was found between the side injected with BTXA and the saline injected side (control) (p<0.001). Facial lifting was achieved in 58.66 percent of the sides injected with BTXA. Forty-four percent of patients were very satisfied. Older patients showed better improvement than younger patients (p=<0.001). The results persisted for 16 weeks. No adverse effects were observed. CONCLUSION: Our results suggest that intradermal injection of BTXA could be a safe and effective therapeutic option for face lifting.
Keywords: Nonsurgical face lifting; intradermal botulinum toxin A injection; mesobotox; microbotox.
Copyright © 2020. Matrix Medical Communications. All rights reserved.
Conflict of interest statement
FUNDING:No funding was provided for this article. DISCLOSURES:The authors report no conflicts of interest relevant to the content of this article.
Figures
References
-
- Ascher B, Zakine B, Kestemont P et al. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol. 2004;51:223–233. - PubMed
-
- Austin HW. The lip lift. Plast Reconstr Surg. 1968;77:990–994. - PubMed
-
- Berry MG, Stanek JJ. Botulinum neurotoxin A: a review. J Plast Reconstr Aesthet Surg. 2012;65:1283–1291. - PubMed
-
- Seo KK. Seo KK. Springer; Singapore: 2017. Multiple Intradermal Botulinum Toxin Injections.Botulinum Toxin for Asians.
LinkOut - more resources
Full Text Sources